Ian C. Sanderson - Net Worth and Insider Trading
Ian C. Sanderson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ian C. Sanderson owns 1 companies in total, including Astria Therapeutics Inc (ATXS) .
Click here to see the complete history of Ian C. Sanderson’s form 4 insider trades.
Insider Ownership Summary of Ian C. Sanderson
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATXS | Astria Therapeutics Inc | 2015-06-24 | CFO and Treasurer |
Ian C. Sanderson Trading Performance
Ian C. Sanderson Ownership Network
Ian C. Sanderson Owned Company Details
What does Astria Therapeutics Inc do?
Who are the key executives at Astria Therapeutics Inc?
Ian C. Sanderson is the CFO and Treasurer of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .
Astria Therapeutics Inc (ATXS) Insider Trades Summary
Over the past 18 months, Ian C. Sanderson made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 4,295,958 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .
In summary, during the past 3 months, insiders sold 0 shares of Astria Therapeutics Inc (ATXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 4,295,958 shares were bought by its insiders, resulting in a net purchase of 4,275,958 shares.
Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Astria Therapeutics Inc Insider Transactions
Ian C. Sanderson Mailing Address
Above is the net worth, insider trading, and ownership report for Ian C. Sanderson. You might contact Ian C. Sanderson via mailing address: C/o Catabasis Pharmaceuticals, Inc., One Kendall Sq. Bldg. 1400e Suite B14202, Cambridge Ma 02139.